Skip to main content
Equibles

Parkside Financial Bank & Trust

Bank

Position in ROIV — Roivant Sciences Ltd.

CIK 1455267 SAINT LOUIS, MO
Back to ROIV Full portfolio

Position in ROIV

as of Jun 30, 2026 · filed Sep 4, 2026
Position Value
$47,038,901
+$10,221,059 QoQ
Shares Held
1,329,158
-0.0% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
3.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Parkside Financial Bank & Trust holds $49,351,632 across 127 Biotechnology names. ROIV ranks #1 (95.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
This page 		1,329,158 $47,038,901
2 HALO
Halozyme Therapeutics, Inc.
 5,790 $453,182
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 759 $377,017
4 TECH
BIO-TECHNE Corp
 3,596 $254,056
5 MRNA
Moderna, Inc.
 1,774 $124,233
6 REGN
Regeneron Pharmaceuticals, Inc.
 167 $104,131
7 DNTH
Dianthus Therapeutics, Inc. /DE/
 1,050 $102,354
8 VKTX
Viking Therapeutics, Inc.
 2,302 $89,801

All Filings in ROIV

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $47,038,901 1,329,158
2026-03-31 $36,817,842 1,329,164
2025-12-31 $25,318,605 1,166,756
2025-09-30 $10,568,607 698,520
2025-06-30 $14,758,527 1,309,541
2025-03-31 $6,194,513 613,926
2024-12-31 $2,436 206
2024-09-30 $2,250 195
2024-06-30 $2,061 195
2024-03-31 $2,055 195
2023-12-31 $2,189 195
2023-09-30 $2,277 195
2023-06-30 $1,965 195
2023-03-31 $1,439 195